Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
about
Targeting angiogenesis in squamous non-small cell lung cancerMONGKIE: an integrated tool for network analysis and visualization for multi-omics data.Automated network analysis identifies core pathways in glioblastoma.Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2.Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasisTranscriptional repression of ANGPT1 by histone H3K9 demethylase KDM3B.Molecular regulation of lymphangiogenesis in development and tumor microenvironment.Tie2 Regulates Tumor Metastasis of Oral Squamous Cell Carcinomas.Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth.Aflibercept and Ang1 supplementation improve neoadjuvant or adjuvant chemotherapy in a preclinical model of resectable breast cancer.Novel targets for VEGF-independent anti-angiogenic drugs.Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.Role of rare germline copy number variation in melanoma-prone patients.Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice.Angiopoietin-1 deficiency increases tumor metastasis in mice.Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway.Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer.CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer.
P2860
Q26861341-1CD9B825-F2A3-4914-BC8D-BE788F470CD3Q27335661-A197D14D-4700-415F-969F-3A6919A1E6BBQ33532647-2D6B486C-C655-485E-B8D2-99F75F32BF93Q33908508-1FF31986-A8EF-4BE9-8DB0-B91091683F27Q34266010-0D2403DF-8686-4637-BF54-EEB331BF2588Q35695381-600D7FD8-5F77-4099-8E8B-BE9E87D0B99EQ35842980-882D9281-5677-45E5-8E3C-BD36467DD980Q36079464-4AFB9EEA-45F3-4CE5-A260-C4827A2D3E02Q36284953-4EBC3EB4-652D-464D-B97F-3F85999BF411Q36764938-3B4B8977-23F2-4E7C-81F6-4FD3F245852EQ36962605-5736B398-1D8A-4E27-A0BF-030C6073DCA8Q37411781-62592BF4-D1BF-42B8-9DB1-E3FB9B422A61Q37984612-CD730254-47F2-4D2C-AC08-663D0F1AB7B9Q38877104-5331C1B6-C6CE-4C4A-A982-8FF45A4A118AQ38889379-89007F68-D406-4909-B455-96B087C94F65Q39652101-AA2F801E-BD47-46F8-AAA0-18271C9954DDQ41363001-21948B2F-D0B3-4530-A3F4-282AEBD9F144Q42147633-2CBEF909-DC96-4C54-9F41-D2FCAA23766CQ49200404-E27CC920-3BA9-49CA-9912-B56DDDDD0B56Q49544357-3F92874C-3722-4506-B676-6EB663CF010DQ55322297-D4411792-A717-4FBB-B2F3-81BDC4CF5AF7
P2860
Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Angiopoietin-1 overexpression ...... and metastasis establishment.
@en
Angiopoietin-1 overexpression ...... and metastasis establishment.
@nl
type
label
Angiopoietin-1 overexpression ...... and metastasis establishment.
@en
Angiopoietin-1 overexpression ...... and metastasis establishment.
@nl
prefLabel
Angiopoietin-1 overexpression ...... and metastasis establishment.
@en
Angiopoietin-1 overexpression ...... and metastasis establishment.
@nl
P2093
P50
P1433
P1476
Angiopoietin-1 overexpression ...... and metastasis establishment.
@en
P2093
Caiping Chen
Chaojun Li
Gou Young Koh
Huilian Huang
Kyung Eun Kim
Tanja Holopainen
Wencan Han
P304
P356
10.1158/0008-5472.CAN-08-4654
P407
P577
2009-06-01T00:00:00Z